Are You a Biotech Company Eyeing an IPO? Be Sure to Assess These 3 Areas First
The initial public offering (IPO) market for biotech companies has picked up steam in 2017, following a lackluster year (2016) that saw the fewest biotech IPOs since 2012. The positive buzz biotech stocks have been generating of late has many startups and other private firms in the sector wondering if now is the time to […]
